MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

RANKL/TNFSF11 Protein, Human

MCE 站：RANKL/TNFSF11 Protein, Human

RANKL (TNFSF11)，一种 II 型跨膜蛋白，是 NF-κB 受体激活剂 (RANK) 的配体。RANKL 是 RANK 的激活剂。当与 RANK 结合后，其诱导单核细胞/巨噬细胞谱系细胞分化为破骨细胞，并进一步导致破骨细胞前体成熟。因此，RANKL 对于破骨细胞成熟、骨骼建模和骨骼重塑，以及淋巴结 (LN) 的发育至关重要。RANKL/TNFSF11 Protein, Human 是一种由 E.coli 产生的重组人 RANKL (I140-D317)，不带标签

Synonyms: rHuRANK L/TNFSF11; TRANCE; CD254

Species: Human

Source: E. coli

Biological Activity: The ED₅₀ is 0.15 μg/mL as measured.

研究背景：RANKL (TNFSF11) belongs to TNF family. RANKL is a type II transmembrane protein ａnd is a receptor activator of NF-κB (RANK) ligand. RANKL is an activator of RANK. RANKL binds to RANK ａnd induces the differentiation of monocyte/macrophage-lineage cells into osteoclasts ａnd leads to osteoclast precursor maturation. In bone tissue, RANKL is expressed by osteoblasts, osteocytes ａnd immune cells, especially in osteoblasts ａnd osteocytes. RANKL is also expressed by T cells ａnd increases proliferation ａnd survival of dendritic cells.
Human RANKL shares 82.02% ａnd 84.44% common aa identity with mouse ａnd rat respectively. Human RANKL consists of cytoplasmic domain (1-47), helical domain (48-68), ａnd extracellular domain (69-317). The soluble chain (140-317) is released when cleaved by enzymes such as matrix metalloproteinases (MMP3 or 7) ａnd ADAM.
RANKL is critical for osteoclasts maturation, bone modeling, ａnd bone remodeling, as well as the development of lymph nodes (LNs).

蛋白编号：O14788 (I140-D317)

基因 ID：8600

产品分类：细胞因子和生长因子  |  肿瘤坏死因子超家族  |  肿瘤坏死因子配体  |  核因子-κB 受体激活因子配体  |  CD 抗原  |  T 细胞 CD 蛋白  |  RANKL/CD254  |  CD 抗原  |  巨噬细胞 CD 蛋白  |  RANKL/CD254

Categories：Cytokines ａnd Growth Factors  |  TNF Superfamily  |  TNF Superfamily Ligands  |  RANKL  |  CD Antigens  |  T Cell CD Proteins  |  RANKL/CD254  |  CD Antigens  |  Macrophage CD Proteins  |  RANKL/CD254

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿*全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。